Skip to main content

Table 4 Prevalence of HPyV6 and HPyV7 in non-cutaneous other human malignancies

From: Emerging role of human polyomaviruses 6 and 7 in human cancers

Tumor

Specimen

Samples n

Method

HPyV6 Positive n (%)

HPyV7 Positive n (%)

Reference

BC

FF

54

rt-PCR

1 (2)

1 (2)

[75]

LSCC

FF

7

Luminex platform (Multiplex PCR)

1 (14.3)

ND

[76]

TETs

FFPE

37

FISH/PCR/Seq/IHC

ND

23 (62.2)

[31]

TSCC

FF

38

qPCR

2 (5.3)

1 (2.6)

[57]

TC

FF and FFPE

112

qPCR

6 (5.4)

2 (1.8)

[58]

CCA

FFPE

42

PCR/FISH/RISH/IHC

4 (9.5)

19 (45.2)

[77]

  1. BC breast cancer, CCA cholangiocarcinoma, FFPE formalin-fixed paraffin-embedded, FF Freshly frozen tissue, FISH fluorescence in situ hybridization, LSCC laryngeal squamous cell carcinoma, ND not detected, PCR polymerase chain reaction, qPCR quantitative polymerase chain reaction, rt-PCR real-time polymerase chain reaction, RISH RNA fluorescence in situ hybridization, Seq Sanger sequencing, TC tonsillar carcinoma, TETs thymic epithelial tumors, TSCC tonsillar squamous cell carcinoma